Compare Akerna Corp (KERN) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
Akerna Corp (KERN)
$6.27
+24.64%
$376.3M
Ancillary
Ancillary Sector Peers
All Ancillary cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
| Ticker | Name | Price | Change % | MCap |
|---|---|---|---|---|
| SMG | Scotts Miracle-Gro | $60.96 | +0.96% | $3.54B |
| TPB | Turning Point Brands | $90.62 | +0.69% | $1.73B |
| LFLY | Leafly Holdings | $135.50 | +17.98% | $271.0M |
| AGFY | Agrify Corp | $47.12 | +4.71% | $94.2M |
| MAPS | WM Technology (Weedmaps) | $0.68 | -7.27% | $73.0M |
| FORA | Forian Inc | $2.05 | -0.97% | $63.7M |
| GRWG | GrowGeneration | $1.06 | -2.75% | $63.4M |
| GRAMF | TPCO Holding (The Parent Company) | $0.16 | -12.99% | $45.7M |
| HYFM | Hydrofarm Holdings | $1.19 | -6.30% | $5.6M |
| GNLN | Greenlane Holdings | $0.82 | -1.84% | $4.1M |
| FNNZF | FinCanna Capital | $0.00 | +38.10% | $545.2K |
Top Matchups by Market Cap
Companies closest to Akerna Corp in market capitalization — the most meaningful head-to-head comparisons.
Cross-Sector Comparisons
Top cannabis companies outside the Ancillary sector. Compare across different business models and market segments.
Jazz Pharmaceuticals
MCap: $10.99B
Curaleaf Holdings
MCap: $1.80B
Green Thumb Industries
MCap: $1.54B
Innovative Industrial Properties
MCap: $1.48B
Trulieve Cannabis
MCap: $1.22B
Comparing KERN in the Cannabis Market
Akerna Corp (KERN) is a Ancillary-sector cannabis company trading at $6.27 per share with a market capitalization of $376.3M. Among its Ancillary peers, KERN ranks #3 by market cap, with trailing twelve-month revenue of $6.8M and a gross margin of 4.0%. The stock has moved +24.64% in the current session, trading on the NASDAQ exchange.
When comparing KERN against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (55.0x), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $5.1M). The comparison tables above allow you to evaluate Akerna Corp relative to 11 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does KERN compare to other Ancillary stocks?+
What is KERN's biggest competitor?+
Is KERN overvalued compared to its peers?+
Which cannabis stock has better margins than KERN?+
Can I compare KERN to stocks in other cannabis sectors?+
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.